I use to compare PYC to IMU; but PYC has become its own multi-hydra beast, seemingly able to target any tissue/cellular type at will.
There was a gentleman at one of PYC’s local scientific fireside chats that queried about oncology targets - SF replied they are keen to pursue/have the team/capability - just not yet given priority list/funding constraint.
This may seem bold as we’re not even in clinic yet, but I think PYC will prove to be a game changer for precision medicine
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)